Asia Pacific Medical Thawing System Market By Product Type, By Sample Type, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

The Asia Pacific Medical Thawing System Market is expected to witness market growth of 12% CAGR during the forecast period (2020-2026).

The region comprises of growing economies, significantly China, India, and Japan. These nations consist of a huge number of patients with a high chronic disease rate. A rise in the number of chronic diseases that result in failures of organs is anticipated to fuel the demand for thawed blood. These nations are creating devices that are innovative and advanced and offer different ultra-modern surgical procedure choices with thriving medical tourism. Comparatively, the lower cost of treatment in the region is the factor that attracts a huge number of patients to visit for medical reasons. These components are anticipated to boost the growth in the Asia Pacific region.

The medical thawing systems market is fueled by the existence of big biopharmaceutical organizations that deploy these frameworks in their production units. With the increasing regional increment of biopharmaceutical businesses owing to the rising product manufacturing in the region, led to the growth of medical thawing systems. In these industries, medical thawing systems are transferred with containers for the cycle of development and aseptic transfers from lab to industrial scales. Thawing systems are equipped with three main elements: a cooling and heating unit, a container, and a thawing instrument. The container is mostly utilized for rapid fast freezing, thawing, and transporting biopharmaceutical items. The thawing instrument is utilized for the smooth execution of the batch process.

Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Manual
• Automated

By Sample Type

• Blood
• Ovum
• Semen
• Embryo
• Others

By End Use

• Blood Bank & Transfusion centers
• Hospitals
• Tissue Banks
• Biotechnology & Pharma
• Other End Uses

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• General Electric (GE) Co. (GE Healthcare)
• Thermo Fisher Scientific, Inc.
• Cardinal Health, Inc.
• Helmer Scientific, Inc.
• Sarstedt AG & Company
• Boekel Scientific, Inc.
• Barkey GmbH & Co. KG
• BioCision LLC
• Sartorius AG
• CytoTherm LP

Unique Offerings

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free